2023-05-01 2024-04-30 false Capium Accounts Production 1.1 14046943 2023-05-01 2024-04-30 14046943 bus:AbridgedAccounts 2023-05-01 2024-04-30 14046943 bus:FRS102 2023-05-01 2024-04-30 14046943 bus:AuditExemptWithAccountantsReport 2023-05-01 2024-04-30 14046943 bus:SmallCompaniesRegimeForAccounts 2023-05-01 2024-04-30 14046943 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 14046943 2023-05-01 2024-04-30 14046943 2024-04-30 14046943 bus:RegisteredOffice 2023-05-01 2024-04-30 14046943 core:WithinOneYear 2024-04-30 14046943 core:AfterOneYear 2024-04-30 14046943 1 2023-05-01 2024-04-30 14046943 bus:Director1 2023-05-01 2024-04-30 14046943 bus:Director1 2024-04-30 14046943 bus:Director1 2022-04-14 2023-04-30 14046943 2022-04-14 14046943 bus:LeadAgentIfApplicable 2023-05-01 2024-04-30 14046943 2022-04-14 2023-04-30 14046943 2023-04-30 14046943 core:WithinOneYear 2023-04-30 14046943 core:AfterOneYear 2023-04-30 14046943 bus:EntityAccountantsOrAuditors 2022-04-14 2023-04-30 14046943 core:PlantMachinery 2023-05-01 2024-04-30 14046943 core:PlantMachinery 2024-04-30 14046943 core:PlantMachinery 2023-04-30 14046943 core:FurnitureFittings 2023-05-01 2024-04-30 14046943 core:FurnitureFittings 2024-04-30 14046943 core:FurnitureFittings 2023-04-30 14046943 core:ComputerEquipment 2023-05-01 2024-04-30 14046943 core:ComputerEquipment 2024-04-30 14046943 core:ComputerEquipment 2023-04-30 14046943 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-04-30 14046943 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-04-30 14046943 core:CostValuation core:Non-currentFinancialInstruments 2024-04-30 14046943 core:CostValuation core:Non-currentFinancialInstruments 2023-04-30 14046943 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-04-30 14046943 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-04-30 14046943 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-04-30 14046943 core:Non-currentFinancialInstruments 2024-04-30 14046943 core:Non-currentFinancialInstruments 2023-04-30 14046943 core:ShareCapital 2024-04-30 14046943 core:ShareCapital 2023-04-30 14046943 core:RetainedEarningsAccumulatedLosses 2024-04-30 14046943 core:RetainedEarningsAccumulatedLosses 2023-04-30 14046943 dpl:Item1 2023-05-01 14046943 dpl:Item1 2024-04-30 14046943 dpl:Item1 2022-04-14 14046943 dpl:Item1 2023-04-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 14046943
England and Wales

 

 

 

AD CLINIC 3 LIMITED


Abridged Accounts
 


Period of accounts

Start date: 01 May 2023

End date: 30 April 2024
Accountant’s report
You consider that the company is exempt from an audit for the year ended 30 April 2024 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
SJPR ACCOUNTANTS LTD
30 April 2024



....................................................

SJPR ACCOUNTANTS LTD

225 Clapham Road
London
SW9 9BE
23 January 2025
1
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 17,289    23,267 
17,289    23,267 
Current assets      
Debtors 602   
Cash at bank and in hand 802    1,380 
1,404    1,380 
Creditors: amount falling due within one year (248)   (2,231)
Net current assets 1,156    (851)
 
Total assets less current liabilities 18,445    22,416 
Net assets 18,445    22,416 
 

Capital and reserves
     
Called up share capital 100    100 
Profit and loss account 18,345    22,316 
Shareholders' funds 18,445    22,416 
 


For the year ended 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the board of directors on 23 January 2025 and were signed on its behalf by:


-------------------------------
Orlanda Isabel Dos Santos Amaral
Director
2
General Information
AD CLINIC 3 LIMITED is a private company, limited by shares, registered in England and Wales, registration number 14046943, registration address 75 Wilton Road, London, SW1V 1DE.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery 20% Straight Line
Fixtures and Fittings 20% Straight Line
Computer Equipment 33.33% Straight Line
2.

Average number of employees

Average number of employees during the year was 2 (2023 : 2).
3.

Tangible fixed assets

Cost or valuation Plant and Machinery   Fixtures and Fittings   Computer Equipment   Total
  £   £   £   £
At 01 May 2023 25,140    2,250    1,500    28,890 
Additions      
Disposals      
At 30 April 2024 25,140    2,250    1,500    28,890 
Depreciation
At 01 May 2023 4,629    471    523    5,623 
Charge for year 5,028    450    500    5,978 
On disposals      
At 30 April 2024 9,657    921    1,023    11,601 
Net book values
Closing balance as at 30 April 2024 15,483    1,329    477    17,289 
Opening balance as at 01 May 2023 20,511    1,779    977    23,267 


3